Co-Authors
This is a "connection" page, showing publications co-authored by Mahmoud Ibrahim and Mohamed-Elamir Hegazy.
Connection Strength
4.600
-
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Mar Drugs. 2021 Jul 13; 19(7).
Score: 0.956
-
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors. Molecules. 2021 Apr 05; 26(7).
Score: 0.938
-
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Protein J. 2021 06; 40(3):296-309.
Score: 0.922
-
In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2021 09; 39(15):5756-5767.
Score: 0.893
-
Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery. J Biomol Struct Dyn. 2021 09; 39(15):5722-5734.
Score: 0.891